National Bank of Canada
UTHR icon

National Bank of Canada’s United Therapeutics UTHR Stock Holding History

National Bank of Canada’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$464K Sell
781
-7,051
-90% -$3.51M ﹤0.01% 1409
2025
Q4 		$3.82M Buy
7,832
+7,552
+2,697% +$3.52M ﹤0.01% 928
2025
Q3 		$117K Buy
280
+17
+6% +$5.72K ﹤0.01% 1713
2025
Q2 		$75.6K Buy
263
+91
+53% +$27.2K ﹤0.01% 1862
2025
Q1 		$53K Sell
172
-2
-1% -$685 ﹤0.01% 1867
2024
Q4 		$61.5K Buy
174
+12
+7% +$4.41K ﹤0.01% 1879
2024
Q3 		$58K Sell
162
-24
-13% -$8.11K ﹤0.01% 1669
2024
Q2 		$59.3K Sell
186
-33
-15% -$8.73K ﹤0.01% 1638
2024
Q1 		$57.9K Sell
219
-21,312
-99% -$4.81M ﹤0.01% 1707
2023
Q4 		$4.89M Sell
21,531
-19,637
-48% -$4.53M 0.01% 774
2023
Q3 		$9.15M Buy
41,168
+23,956
+139% +$5.52M 0.01% 629
2023
Q2 		$3.85M Buy
17,212
+12,936
+303% +$2.87M 0.01% 796
2023
Q1 		$963K Buy
4,276
+4,071
+1,986% +$1M ﹤0.01% 1069
2022
Q4 		$57K Sell
205
-3,719
-95% -$939K ﹤0.01% 1704
2022
Q3 		$839K Buy
3,924
+3,764
+2,353% +$841K ﹤0.01% 1033
2022
Q2 		$38K Sell
160
-5,982
-97% -$1.22M ﹤0.01% 1842
2022
Q1 		$1.1M Buy
6,142
+6,000
+4,225% +$1.14M ﹤0.01% 1065
2021
Q4 		$31K Buy
+142
New +$27.9K ﹤0.01% 2040

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

National Bank of Canada's UTHR Position: Q1 2026 in Review

National Bank of Canada reduced its United Therapeutics (UTHR) stake by 90% in Q1 2026, selling an estimated $3.51M and leaving 781 shares worth $464K. The position accounts for ﹤0.01% of the portfolio, ranked #1409.

National Bank of Canada first reported a position in UTHR in Q4 2021 and has held it in 18 quarters since. The position peaked at $9.15M in Q3 2023. 851 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • National Bank of Canada held 781 shares of United Therapeutics worth $464K as of Q1 2026.
  • National Bank of Canada sold 7,051 United Therapeutics shares in Q1 2026, an estimated $3.51M.
  • United Therapeutics made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #1409 holding.
  • National Bank of Canada first reported a position in United Therapeutics in Q4 2021 and has held it in 18 quarters since.
  • National Bank of Canada's United Therapeutics position peaked at $9.15M in Q3 2023.
  • 851 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.